K140775 is an FDA 510(k) clearance for the TURBO-ELITE ATHERECTOMY CATHETERS, TURBO TANDEM SYSTEM. Classified as Catheter, Peripheral, Atherectomy (product code MCW), Class II - Special Controls.
Submitted by Spectranetics Corporation (Colorado Springs, US). The FDA issued a Cleared decision on July 23, 2014 after a review of 117 days - within the typical 510(k) review window.
This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.4875 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.
NCT01330628
Completed
Interventional
Industry-sponsored
Randomized Study of Laser and Balloon Angioplasty Versus Balloon Angioplasty to Treat Peripheral In-stent Restenosis
EXCImer Laser Randomized Controlled Study for Treatment of FemoropopliTEal In-Stent Restenosis
| Condition studied |
Peripheral Arterial Disease |
| Study design |
Parallel |
| Eligibility |
All sexes
· 18 Years+
|
| Principal investigator |
Eric J Dippel, MD |
| Sponsor |
Spectranetics Corporation
(industry)
|
Started 2011-06-01
→
Primary completion 2014-03-01
→
Completed 2015-05-01
Primary outcome
Freedom From Target Lesion Revascularization (TLR)
View full study on ClinicalTrials.gov